Posted by Michael Wonder on 18 Aug 2021
NICE publishes final guidance on the use of a topical gel for patients with a rare cancer
18 August 2021 - Chlormethine gel for is used for the treatment of patients with mycosis fungoides type cutaneous T-cell lymphoma.
Chlormethine gel (Ledaga) is recommended as an option for the treatment of adults with early stage (stage 1A, 1B, and 2A) mycosis fungoides type cutaneous T‑cell lymphoma.
